Wrinkle reduction Yes Regeneration and healing Yes Antioxidant effects Yes Improved skin elasticity Yes Safety of use Yes Scientific data and sources Research summary Level of evidence Preliminary Number of included studies: 20 8 studies 5 studies 4 studies 1 study 1 study 1 study Final comment: Although systematic literature analyses and results from in vitro and animal model studies indicate the effectiveness of GHK-Cu in skin regeneration and wrinkle reduction, there are no direct randomized controlled trials in humans
The Science How Does Tesamorelin Work
Mounjaro is a dual-targeting drug as it also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor, making it the first-in-class GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes
Tissue and Skin Regeneration: Stimulates collagen and elastin production for stronger, healthier skin Improves wound healing and reduces scarring Enhances skin tone, texture, and elasticity Promotes even skin tone and firmness Cellular Repair and Recovery: Increases blood flow and oxygen delivery to tissues Reduces inflammation and oxidative stress Supports regeneration of connective tissue and muscle fibers Encourages overall rejuvenation and cellular health Anti-Aging and Aesthetic Support: Helps reduce fine lines, wrinkles, and visible signs of aging Promotes smoother, firmer, more youthful-looking skin May support hair health and scalp vitality What are the side effects of GHK-Cu
To be safe, remember that the recommended daily intake for most people is Do not exceed the UL of 4,000 IU (100 mcg) without consulting a doctor or dietitian

Use Case Recommendations# Choose HGH 191AA When:# Diagnosed GH deficiency requiring comprehensive hormone replacement Growth failure in pediatric patients with documented GH deficiency Body composition goals requiring both fat loss and lean mass gain Bone health is a treatment priority alongside metabolic optimization Clinical setting with proper medical oversight and monitoring capability Choose HGH Fragment 176-191 When:# Isolated fat-loss research is the objective without desire for anabolic effects Insulin sensitivity must be preserved and cannot tolerate GH-induced resistance IGF-1 elevation is contraindicated or undesirable Research context studying GHR-independent lipolytic mechanisms Simpler monitoring is preferred without the need for IGF-1 tracking Can They Be Combined?# Combining full-length GH with its own fragment would be pharmacologically redundant